matthieu resche-rigon
Professor
FranceResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Matthieu Resche-Rigon is a Professor at Université Paris Diderot UFR de Médecine, affiliated with Saint-Louis Hospital - APHP in France. His research primarily focuses on the effectiveness and safety of systemic treatments for various cancers, including Kaposi sarcoma and dermatofibrosarcoma protuberans. Additionally, he has conducted studies on statistical methodologies in medical research, particularly regarding cause-specific Cox models and their applications in clinical outcomes.
Articles (4)
Although systemic treatments are warranted in aggressive forms of classic and endemic Kaposi sarcomas (KS), therapeutic guidelines are lacking for those nonimmunodeficient subtypes. In this retrospective multicentre study, we showed that paclitaxel, liposomal doxorubicin and low-dose interferon had good overall response rates for nonimmunodeficient KS with acceptable tolerance profiles. In addition, we highlighted the aggressiveness of endemic KS compared with classic KS with a higher risk of dissemination and response depletion as progression proceeded.
Year:
2024
Year:
2022
Year:
2021
Year:
2020
Collaborators (1)
Céleste Lebbé
Université Paris Cité
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.